ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
3.800
+0.230 (6.44%)
Jan 22, 2026, 4:00 PM EST - Market closed
ADC Therapeutics Market Cap
ADC Therapeutics has a market cap or net worth of $470.73 million as of January 23, 2026. Its market cap has increased by 150.95% in one year.
Market Cap
470.73M
Enterprise Value
693.43M
1-Year Change
150.95%
Ranking
Category
Stock Price
$3.80
Market Cap Chart
Since May 15, 2020, ADC Therapeutics's market cap has decreased from $2.04B to $470.73M, a decrease of -76.96%. That is a compound annual growth rate of -22.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 470.73M | 7.65% |
| Dec 31, 2025 | 437.29M | 127.27% |
| Dec 31, 2024 | 192.41M | 43.49% |
| Dec 29, 2023 | 134.10M | -56.31% |
| Dec 30, 2022 | 306.95M | -80.20% |
| Dec 31, 2021 | 1.55B | -37.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| May 15, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bicycle Therapeutics | 500.84M |
| Aclaris Therapeutics | 490.80M |
| Monopar Therapeutics | 481.08M |
| Vanda Pharmaceuticals | 478.68M |
| Absci | 475.17M |
| Anavex Life Sciences | 473.54M |
| 4D Molecular Therapeutics | 462.22M |
| Contineum Therapeutics | 461.37M |